COVID-19 PANDEMIC IS ASSOCIATED WITH REDUCED ADMISSIONS FOR STEMI, INCREASED ISCHAEMIA TIME, MORTALITY REMAINS THE SAME: DATA FROM A LOW COVID-19 MORBIDITY COUNTRY
| العنوان: | COVID-19 PANDEMIC IS ASSOCIATED WITH REDUCED ADMISSIONS FOR STEMI, INCREASED ISCHAEMIA TIME, MORTALITY REMAINS THE SAME: DATA FROM A LOW COVID-19 MORBIDITY COUNTRY |
|---|---|
| المؤلفون: | Povilas Budrys, Pranas Šerpytis, Vilhelmas Bajoras, Aleksandr Volodko, Aurelija Martinonyte, Giedrius Davidavicius, K Cerlinskaite, Jelena Celutkiene, Greta Rodevic, Egle Urbonaite, Ignas Badaras, Mindaugas Lizaitis, Laurynas Dieckus |
| المصدر: | Journal of the American College of Cardiology |
| بيانات النشر: | Elsevier BV, 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | medicine.medical_specialty, First medical contact, Coronavirus disease 2019 (COVID-19), business.industry, medicine.medical_treatment, Ischemia, Percutaneous coronary intervention, medicine.disease, Retrospective data, Spotlight on Special Topics, Conventional PCI, Emergency medicine, Pandemic, medicine, Population study, Cardiology and Cardiovascular Medicine, business |
| الوصف: | Background The COVID-19 pandemic has put on an enormous pressure on the health system, aggravating timely diagnosis and treatment of other diseases, resulting in increased mortality. We aimed to analyse whether COVID-19 pandemic had an impact on the treatment of patients suffering from acute ST segment elevation myocardial infarction (STEMI) in a country with a low COVID-19 morbidity during the first wave. Methods We conducted a retrospective data analysis from a tertiary centre in Lithuania. Patients who presented with STEMI were analysed. Data was collected from March 1 to June 30 in 2020 (quarantine period in Lithuania) and during the same period in 2019. Final study population was 317 patients. Patients were divided into two groups: 2020 year (n=146) and 2019 year (n=171). The primary study endpoint was all-cause mortality during 3 months follow-up. Secondary endpoint was first medical contact (FMC) to percutaneous coronary intervention (PCI) time. Results Results are demonstrated in Table 1. All-cause mortality during 3 months follow up did not differ significantly (10.5% in 2019 and 6.8% in 2020, p=0.341). In 2019 74.3% of patients received PCI within recommended 120 minutes from the FMC, while this number was only 51.7% in 2020, p=0.024. [Formula presented] Conclusion There was a 9.3% reduction of admissions for STEMI during the first wave of COVID-19. FMC to PCI time has increased significantly in 2020, however, it did not translate into worse survival during follow-up. |
| تدمد: | 0735-1097 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3604408bbe6e284693a276f71b8fd1b9 https://doi.org/10.1016/s0735-1097(21)04458-2 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....3604408bbe6e284693a276f71b8fd1b9 |
| قاعدة البيانات: | OpenAIRE |
Full Text via ClinicalKey كن أول من يترك تعليقا!